Tommy Thompson’s shilling for a biotech client

Last month, former Health & Human Services Secretary Tommy Thompson announced he was seeking the GOP nomination for Wisconsin’s open U.S. Senate seat. A week before that, though, Thompson was discussing the 9/11 anniversary on the air, and he promoted an anthrax vaccine that happens to be made by one of his consulting clients, PharmAthene.

Bill Flook at the Washington Business Journal reports this tale of non-disclosure and conflicting interests:

Thompson, former Wisconsin governor and George W. Bush’s first Health and Human Services secretary, failed to mention his consulting work for PharmAthene when he showered on the biotech such praise as “I think they’re doing an excellent job, and I think our country needs to get behind them” in a recent ABC News interview. He appeared on the program not as a partner at Akin Gump Strauss Hauer & Feld    LLP or as a PharmAthene consultant, but as a former HHS chief – presumably – brought on to speak as an expert on the nation’s biodefense capabilities. He instead used that authority to slip in praise for an Akin Gump client.

This isn’t the first time Thompson has worn his elder statemen hat while plugging his clients’ interests. As I wrote when Thompson began considering a run, while representing health-care companies standing to profit from ObamaCare, he expressed support for the legislation:

Akin Gump’s lobbying clients include insurance giant Aetna, leading drug company Pfizer, plus a handful of small pharmaceutical makers and the Alliance for a Stronger FDA, led by top drug makers such as Pfizer, Merck, and Eli Lilly. Thompson is not registered as a lobbyist, which means more than 80 percent of his work for Akin Gump must be non-lobbying work, such as advising clients.
In October 2009, as the Senate Finance Committee passed its version of the health care bill, Thompson and former House Democratic leader Dick Gephardt issued a joint statement praising the legislation as “another important step toward achieving the goal of health care reform this year.”

Thompson, normally, would seem like shoo-in for the nomination. He’s got statewide name recognition and close ties to the Beltway GOP elite. Also, when you look at his K Street connections and client list, he clearly would be a powerful fundraiser.

But this sort of crony capitalism and corporatism doesn’t go over so well in Republican primaries these days. I wouldn’t be surprised to see proto-Tea Partier Mark Neumann — who, as a congressman was kicked off the Appropriations Committee for not toeing the line — give Thompson a run for his money.

Related Content